Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation
- 1 May 2008
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 93 (6) , F442-F447
Abstract
Background: A single course of maternal glucocorticoid treatment is effective in reducing neonatal mortality after preterm birth. However, in animals, maternal glucocorticoid treatment is associated with lifelong hyperglycaemia and hypertension, and impaired nephrogenesis in offspring. Findings from studies in humans on this topic are highly contradictory due to a number of methodological flaws, and renal function after glucocorticoid exposure has never been assessed. Objectives: To assess in individuals born 2. Conclusions: The reduction in neonatal mortality associated with a single course of maternal betamethasone is not accompanied by long-term metabolical risks in survivors of preterm birth. The only adverse effect found was lower GFR. Although this difference was not clinically relevant at 19 years, it might predict an increased risk of chronic renal failure in prematurely born individuals who were exposed antenatally to betamethasone.Keywords
This publication has 34 references indexed in Scilit:
- Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trialThe Lancet, 2005
- Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice?European Journal of Pediatrics, 2005
- When are observational studies as credible as randomised trials?The Lancet, 2004
- Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescentsThe Journal of Pediatrics, 2004
- Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants?Early Human Development, 2003
- Looking back in time: outcome of a national cohort of very preterm infants born in The Netherlands in 1983Early Human Development, 2000
- Glucocorticoid exposure in utero: new model for adult hypertensionThe Lancet, 1993
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985
- Obstetrical attitudes to glucocorticoid treatment for fetal lung maturation: time for a change?European Journal of Obstetrics & Gynecology and Reproductive Biology, 1984
- ST. THOMAS'S AND GUY'S HOSPITALS, ANNIVERSARY DINNER.The Lancet, 1824